Senior CMC Regulatory Affairs Manager

Alentis Therapeutics, the Claudin-1 Company, is on a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1 and bringing much-needed medicines to patients suffering from solid tumors as well as kidney, liver, and lung fibrosis.

Tasks

The Senior CMC Regulatory Affairs Manager is responsible for defining, leading and executing the CMC regulatory strategy, preparing the regulatory dossiers and supporting worldwide submission activities for Alentis’ pipeline products, including monoclonal antibodies and antibody-drug conjugates. The candidate will be responsible for ensuring compliance with global regulatory requirements and provides insights to guide Alentis’ programs through standard and accelerated regulatory pathways, from IND to BLA. The candidate serves as a CMC regulatory representative within internal cross-functional teams and in regulatory agencies interactions.

Your tasks :

• Develop, implement and execute the CMC regulatory strategy for Alentis’ pipeline products, from IND / CTA clinical stage through BLA / MAA and post-marketing maintenance
• Author, review and prepare for submission CMC sections of regulatory dossiers, including for briefing packages, INDs, IMPDs, BLAs / MAAs
• Lead and coordinate internal review processes to ensure timely delivery of CMC regulatory documentation
• Participate in cross-functional meetings and collaborate closely with key stakeholders to ensure compliance and alignment with development timelines and deliverables
• Support cross-functional teams in devising CMC regulatory strategy, including accelerated pathways
• Address CMC / Quality related requests for information from Health Authorities (FDA, EMA, etc.) according to required deadlines
• Track post-approval CMC commitments, assess the regulatory impact and ensure implementation of the required changes
• Assess and proactively escalate CMC regulatory risks and propose appropriate mitigation strategies
• Support due diligence activities and inspections / audits related to CMC regulatory aspects
• Monitor evolving global CMC regulatory requirements for biologics, including monoclonal antibodies and antibody-drug conjugates

Requirements

Benefits

We offer a competitive salary and opportunities for career growth and development. If you are a highly motivated and skilled scientist looking to join a dynamic and innovative team, please submit your CV.

Candidate needs to hold a Swiss working permit or be an EU citizen eligible to work in Switzerland. The working place is Allschwil, Switzerland with 2 days home office per week.

Alentis Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough treatments for cancer and fibrotic diseases.